- World rank, all time
- #17,741 of 42,892
- Rank in United States
- #3,856 of 8,685
- Research works
- 153 ▲ 24% vs 2013–17
- Citations
- 9.7k 63.5 per fractional work
- Top-10% rate
- 11.4% record average 16.5%
- Open access
- 28% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 31.3×. Every wedge is a field page.
Who are the top researchers at Nektar Therapeutics (United States)?
Ranked on the composite score, Mary Tagliaferri, Jonathan Zalevsky and Ute Hoch lead among researchers whose main affiliation is Nektar Therapeutics (United States).
- 1 Mary Tagliaferri United States · #420,137 worldwide 46 citations · 22 works
- 2 Jonathan Zalevsky United States · #520,890 worldwide 57 citations · 20 works
- 3 Ute Hoch United States · #1,210,932 worldwide 46 citations · 26 works
Which keywords describe research at Nektar Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Nanoparticles, Tumor Microenvironment, Natural Killer Cells, NK Cell Recognition, Tumor Regression and Inhaler Devices.
- Metastatic Breast Cancer
- Spray Drying
- Encapsulation Techniques
- Metastasis
- Biopharmaceuticals
- Topoisomerases
- Genetic Variants
- Inhibitors
- Clinical Trials
- Monoclonal Antibodies
- Antigen Presentation
- Dendritic Cells
- PD-1 and PD-L1
- Chimeric Antigen Receptor
- Leukemia
- Pulmonary Drug Delivery
- Inhaler Devices
- Natural Killer Cells
- Tumor Microenvironment
- Cancer Immunotherapy
- Immunotherapy
- Nanoparticles
- NK Cell Recognition
- Tumor Regression
- Lymphoma
- Chemotherapy
- CAR T Cells
- Immune Checkpoint Blockade
- Immunity
- Innate Immunity
- Tumor Antigen
- Biomarkers
- Targeted Therapy
- Therapeutic Antibodies
- DNA
- Prognostic Factors
- Immunogenicity
- Cyclodextrins
- Solid Dispersions
- Gene Therapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy17▲ 17×14 topics
- Cancer Immunotherapy16▲ 77×2 topics
- Nanoparticles16▲ 7.8×10 topics
- Tumor Microenvironment13▲ 23×5 topics
- NK Cell Recognition11▲ 74×1 topic
- Natural Killer Cells11▲ 74×1 topic
- Tumor Regression11▲ 85×2 topics
- Inhaler Devices11▲ 233×1 topic
- Lymphoma11▲ 48×4 topics
- Pulmonary Drug Delivery11▲ 233×1 topic
- Chemotherapy10▲ 9.6×10 topics
- Leukemia10▲ 100×2 topics
- CAR T Cells10▲ 148×1 topic
- Chimeric Antigen Receptor10▲ 148×1 topic
- Immune Checkpoint Blockade10▲ 114×1 topic
- PD-1 and PD-L110▲ 114×1 topic
- Immunity8▲ 15×5 topics
- Dendritic Cells7▲ 38×2 topics
- Innate Immunity7▲ 13×2 topics
- Antigen Presentation7▲ 43×1 topic
- Tumor Antigen7▲ 53×1 topic
- Monoclonal Antibodies6▲ 28×3 topics
- Biomarkers6▲ 6.4×8 topics
- Clinical Trials6▲ 6.2×9 topics
- Targeted Therapy6▲ 17×5 topics
- Inhibitors5▲ 46×2 topics
- Therapeutic Antibodies5▲ 25×2 topics
- Genetic Variants5▲ 14×2 topics
- DNA4▲ 92×1 topic
- Topoisomerases4▲ 92×1 topic
- Prognostic Factors4▲ 6.1×7 topics
- Biopharmaceuticals4▲ 38×2 topics
- Immunogenicity4▲ 50×2 topics
- Metastasis4▲ 6.9×3 topics
- Cyclodextrins4▲ 99×1 topic
- Encapsulation Techniques4▲ 129×1 topic
- Solid Dispersions4▲ 99×1 topic
- Spray Drying4▲ 129×1 topic
- Gene Therapy3▲ 7.5×4 topics
- Metastatic Breast Cancer3▲ 30×2 topics
Which research topics does Nektar Therapeutics (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Galectins and Cancer Biology and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 2 works
- 2 Immune Cell Function and Interaction Immunology 2 works
- 3 Galectins and Cancer Biology Immunology 1 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Immunotherapy and Immune Responses Immunology 1 works
- 6 T-cell and B-cell Immunology Immunology 1 works
- 7 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 8 Dermatology and Skin Diseases Dermatology 0 works
- 9 Biosimilars and Bioanalytical Methods Immunology 0 works
- 10 Neuroblastoma Research and Treatments Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Nektar Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- San Francisco VA Medical Center
- University of California San Francisco Medical Center
- San Francisco General Hospital
- Institute on Aging
- California Pacific Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.